Free Trial

Universal Beteiligungs und Servicegesellschaft mbH Takes $30.15 Million Position in Healthpeak Properties, Inc. (NYSE:DOC)

Healthpeak Properties logo with Finance background

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,487,557 shares of the real estate investment trust's stock, valued at approximately $30,153,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.21% of Healthpeak Properties at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Mizuho Bank Ltd. purchased a new position in Healthpeak Properties in the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties in the 4th quarter worth about $30,000. Covestor Ltd increased its stake in Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after purchasing an additional 1,152 shares in the last quarter. Kestra Investment Management LLC purchased a new position in Healthpeak Properties in the 4th quarter worth about $45,000. Finally, Kapitalo Investimentos Ltda purchased a new position in Healthpeak Properties in the 4th quarter worth about $46,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on DOC shares. Wells Fargo & Company dropped their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday. Scotiabank dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research note on Monday, May 12th. Wedbush dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Argus reissued a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Robert W. Baird dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat, Healthpeak Properties presently has an average rating of "Moderate Buy" and an average target price of $23.27.

Check Out Our Latest Report on Healthpeak Properties

Healthpeak Properties Stock Down 0.0%

NYSE:DOC traded down $0.01 on Monday, hitting $17.41. 4,933,883 shares of the company's stock traded hands, compared to its average volume of 5,128,300. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 1 year low of $16.64 and a 1 year high of $23.26. The firm has a 50-day moving average price of $18.10 and a 200-day moving average price of $19.67. The company has a market cap of $12.09 billion, a PE ratio of 49.73, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the previous year, the business posted $0.45 EPS. The business's revenue for the quarter was up 15.9% on a year-over-year basis. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. The ex-dividend date was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's dividend payout ratio is 305.00%.

Insider Activity

In other news, Director John T. Thomas purchased 4,200 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the acquisition, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. This represents a 0.52% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Scott M. Brinker purchased 11,337 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The shares were purchased at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares in the company, valued at $3,568,937.84. The trade was a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 29,764 shares of company stock worth $521,909 in the last three months. 0.23% of the stock is owned by insiders.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

See Also

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines